The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Posttreatment after lenvatinib in patients with advanced hepatocellular carcinoma.
 
Keisuke Koroki
No Relationships to Disclose
 
Naoya Kanogawa
No Relationships to Disclose
 
Susumu Maruta
No Relationships to Disclose
 
Sadahisa Ogasawara
Honoraria - Bayer; Eisai; Lilly; Merck
Consulting or Advisory Role - AstraZeneca; Bayer; Chugai Pharma; Eisai; Lilly; Merck
Research Funding - Bayer; Eisai; Lilly
 
Masamichi Obu
No Relationships to Disclose
 
Norio Itokawa
No Relationships to Disclose
 
Masanori Inoue
No Relationships to Disclose
 
Yuki Haga
No Relationships to Disclose
 
Shinichiro Okabe
No Relationships to Disclose
 
Atsuyoshi Seki
No Relationships to Disclose
 
Masanori Atsukawa
No Relationships to Disclose
 
Ei Itobayashi
No Relationships to Disclose
 
Kenji Ito
No Relationships to Disclose
 
Hideaki Mizumoto
No Relationships to Disclose
 
Kazufumi Kobayashi
No Relationships to Disclose
 
Takayuki Kondo
No Relationships to Disclose
 
Eiichiro Suzuki
No Relationships to Disclose
 
Tetsuhiro Chiba
No Relationships to Disclose
 
Makoto Arai
No Relationships to Disclose
 
Naoya Kato
Honoraria - Bayer; Eisai; Lilly
Consulting or Advisory Role - Bayer; Eisai; Lilly
Research Funding - Bayer; Eisai; Lilly; Takeda